Tumors with lymph node metastasis showed higher frequency of SHH and GLI1 positivity (SHH: 79% vs. 51%, P = 0.013; GLI1: 68% vs. 43%, P = 0.039). The gene discussed is GLI1; the disease is metastatic malignant neoplasm in the lymph nodes.